Clinical characteristics and outcomes of pediatric patients with autoimmune gastritis

Abstract

AbstractObjectivesAutoimmune gastritis (AIG) is a rare chronic inflammatory disorder with potential long‐term sequelae including gastric neoplasia. There is limited data on the natural history of pediatric AIG. We aimed to characterize the clinical course and outcomes of children with AIG.MethodsThis was a multicenter retrospective study that included pediatric patients diagnosed with AIG between January 1, 2000 and December 31, 2021. Diagnosis of AIG was based on the demonstration of histological corpus‐predominant atrophic gastritis, with or without positive antiparietal cell (APCA) or anti‐intrinsic factor (IF) antibodies. Demographic, clinical, laboratory, endoscopic, and histologic data were retrieved, along with follow‐up data.ResultsThirty‐three patients, (23 females [69.7%], median age 12.0 [interquartile range 7.0–15.0] years at diagnosis) were identified. Twenty‐two patients (66.7%) had positive APCA and/or anti‐IF serology. The most common presenting manifestation was iron deficiency anemia (75%), and accompanying autoimmune disorders were significantly more common in patients with positive serology (62% vs. 18%, p < 0.05). Pseudo‐pyloric or intestinal‐type metaplasia was present at diagnosis in eight patients (24%), and 11 additional patients (33%) developed metaplasia during a median follow‐up time of 27 (17.5–48.3) months. One patient developed a type 1 gastric neuroendocrine tumor. Helicobacter pylori was identified in only one patient, while two patients had prior eradication. Endoscopic and histologic improvements weren't identified in any patients.ConclusionsAIG should be considered in patients with autoimmunity and resistant iron‐deficiency anemia. H. pylori infection may not be associated with pediatric AIG. The development of neuroendocrine tumor in one patient, and the high rates of metaplasia, highlight the importance of surveillance.